Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Browsing Tag

CHF

53 posts
RRoche
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong 2025 results with 7% sales growth
Read More

Roche’s Board of Directors proposes exchange of Genussscheine for participation certificates (Partizipationsscheine)

  • 2026-02-19
F. Hoffmann-La Roche Ltd Participation certificates (Partizipationsscheine) with a nominal value of CHF 0.001 each will replace the…
RRoche
Is It Time To Reassess Roche Holding (SWX:ROG) After Its Strong Multi Year Share Price Run?
Read More

Looking at the Narrative for Roche After New Trial Results and Strategic Shifts

  • 2026-02-19
Roche Holding’s fair value estimate has edged up to about CHF 312 from roughly CHF 305, supported by…
RRoche
Roche's Q1 Sales Increase Y/Y on Solid Performance of Key Drugs
Read More

Roche’s Q1 Sales Increase Y/Y on Solid Performance of Key Drugs

  • 2026-02-18
Swiss pharma giant Roche Holding AG RHHBY posted strong growth in the first quarter of 2025. Sales increased…
BBasel
Basilea reports strong 2025 full-year results, surpassing revenue and operating profit guidance
Read More

Basilea reports strong 2025 full-year results, surpassing revenue and operating profit guidance

  • 2026-02-18
Basilea Pharmaceutica International Ltd, Allschwil 15% royalty income increase 11% total revenue increase Tripled net cash position Phase…
RRoche
Roche Reports 7% 1H25 Sales Growth, Key Drugs Perform Well
Read More

Roche Reports 7% 1H25 Sales Growth, Key Drugs Perform Well

  • 2026-02-18
Swiss pharma giant Roche Holding AG (RHHBY) reported sales of CHF 30.9 billion for the first half of…
RRoche
Is It Time To Reassess Roche Holding (SWX:ROG) After Its Strong Multi Year Share Price Run?
Read More

How the Narrative Around Roche Is Evolving Amid Analyst Updates and Clinical Shifts

  • 2026-02-17
Roche Holding’s fair value estimate has seen a modest increase, with the latest target rising from CHF 298.64…
RRoche
Roche announces positive phase III results for Gazyva/Gazyvaro in primary membranous nephropathy, marking a significant milestone in this autoimmune disease
Read More

Roche’s Board of Directors proposes exchange of Genussscheine for participation certificates (Partizipationsscheine)

  • 2026-02-16
F. Hoffmann-La Roche Ltd Participation certificates (Partizipationsscheine) with a nominal value of CHF 0.001 each will replace the…
RRoche
Is It Time To Reassess Roche Holding (SWX:ROG) After Its Strong Multi Year Share Price Run?
Read More

Is It Time To Reassess Roche Holding (SWX:ROG) After Its Strong Multi Year Share Price Run?

  • 2026-02-16
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors…
RRoche
Examining Valuation After Recent Share Price Momentum
Read More

Is Roche Holding (SWX:ROG) Still Attractive After A 33% One Year Share Price Gain

  • 2026-02-16
If you are wondering whether Roche Holding is still reasonably priced at around CHF340.80, the current share price…
NNestlé
Is Nestlé (SWX:NESN) Offering A Valuation Opportunity After Recent Share Price Weakness
Read More

How Analysts See the Nestlé Story Changing After Leadership Shakeup and New Targets

  • 2026-02-15
Nestlé’s consensus analyst price target has inched up slightly, moving from CHF 87.75 to CHF 88.05 as analyst…
RRoche
Roche Holding (SWX:ROG) Valuation Check After Recent Share Price Momentum And Conflicting Fair Value Views
Read More

Does Roche Offer Real Value After Solid Returns and Progress in Drug Development?

  • 2026-02-15
Curious if Roche Holding is offering real value right now? You’re not alone, and there’s more to its…
NNovartis
Novartis Expands AI Research Footprint As Kisqali Access Progresses In Canada
Read More

Is It Too Late To Consider Novartis (SWX:NOVN) After Strong Multi‑Year Share Gains?

  • 2026-02-15
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million…
Switzerland
www.europesays.com